Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea
· Delayed Price · Currency is KRW 2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
KOSDAQ:175250 Revenue
Icure Pharmaceutical Incorporation had revenue of 25.14B KRW in the quarter ending September 30, 2025, with 59.79% growth. This brings the company's revenue in the last twelve months to 93.22B, up 53.81% year-over-year. In the year 2024, Icure Pharmaceutical Incorporation had annual revenue of 69.21B with 21.83% growth.
Revenue (ttm)
93.22B
Revenue Growth
+53.81%
P/S Ratio
0.87
Revenue / Employee
423.75M
Employees
220
Market Cap
81.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69.21B | 12.40B | 21.83% |
| Dec 31, 2023 | 56.81B | -2.56B | -4.31% |
| Dec 31, 2022 | 59.37B | -4.92B | -7.65% |
| Dec 31, 2021 | 64.28B | -25.86B | -28.69% |
| Dec 31, 2020 | 90.14B | 29.22B | 47.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Raphas | 32.16B |
| Coreana Cosmetics | 76.53B |
| SR biotek | 1.62B |
| KODI CO., LTD | 79.37B |
| Nowcos | 35.64B |
| TS Trillion | 27.95B |
| INSAN | 35.03B |
| HuM&C | 52.00B |